The 21st century saw a shift in the cholera burden from Asia to Africa.
OBJECTIVES: To examine age differences in mortality and programme attrition amongst paediatric patients treated in four African HIV programmes.
SETTING: Despite major progress in the surveillance of drug-resistant tuberculosis (TB), data are lacking for many low-resource countries.
BACKGROUND: Safety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.
BACKGROUND: Prospective efficacy monitoring of anti-malarial treatments is imperative for timely detection of resistance development.
Despite recent advances, tuberculosis (TB) diagnosis remains imperfect in resource-limited settings due to its complexity and costs, poor sensitivity of available tests, or long times to reporting.
BACKGROUND: There is little evidence on the effectiveness of services for the care of people with mental disorders among refugee populations.
OBJECTIVES AND DESIGN: We used data from a randomized trial of HIV-tuberculosis co-infected patients in Mozambique to determine the incidence and predictors of paradoxical tuberculosis-associated immune reconstitution inflammatory synd
BACKGROUND: The association between cholera in pregnancy and negative fetal outcome has been described since the 19(th) century. However, there is limited published literature on the subject.
